Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

被引:292
作者
Chung, Amy W. [1 ,2 ]
Kumar, Manu P. [3 ]
Arnold, Kelly B. [3 ]
Yu, Wen Han [1 ,3 ]
Schoen, Matthew K. [1 ]
Dunphy, Laura J. [3 ]
Suscovich, Todd J. [1 ]
Frahm, Nicole [4 ]
Linde, Caitlyn [1 ]
Mahan, Alison E. [1 ]
Hoffner, Michelle [1 ]
Streeck, Hendrik [5 ,6 ]
Ackerman, Margaret E. [7 ]
McElrath, M. Juliana [4 ]
Schuitemaker, Hanneke [8 ]
Pau, Maria G. [8 ]
Baden, Lindsey R. [1 ,9 ]
Kim, Jerome H. [5 ,10 ]
Michael, Nelson L. [5 ]
Barouch, Dan H. [1 ,11 ]
Lauffenburger, Douglas A. [3 ]
Alter, Galit [1 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[3] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[5] US Mil HIV Res Program, Dept Mol Virol & Pathogenesis, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
[6] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Biol, D-45141 Essen, Germany
[7] Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA
[8] Crucell Holland BV, NL-2333 Leiden, Netherlands
[9] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02215 USA
[10] Int Vaccine Inst, Seoul 151742, South Korea
[11] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
关键词
EBOLA-VIRUS INFECTION; PROTECTIVE EFFICACY; NEONATAL MICE; ANTIBODY; IGA; CHALLENGES; BINDING; REGION; SERUM;
D O I
10.1016/j.cell.2015.10.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
While antibody titers and neutralization are considered the gold standard for the selection of successful vaccines, these parameters are often inadequate predictors of protective immunity. As antibodies mediate an array of extra-neutralizing Fc functions, when neutralization fails to predict protection, investigating Fc-mediated activitymay help identify immunological correlates and mechanism(s) of humoral protection. Here, we used an integrative approach termed Systems Serology to analyze relationships among humoral responses elicited in four HIV vaccine trials. Each vaccine regimen induced a unique humoral "Fc fingerprint." Moreover, analysis of case: control data from the first moderately protective HIV vaccine trial, RV144, pointed to mechanistic insights into immune complex composition that may underlie protective immunity to HIV. Thus, multi-dimensional relational comparisons of vaccine humoral fingerprints offer a unique approach for the evaluation and design of novel vaccines against pathogens for which correlates of protection remain elusive.
引用
收藏
页码:988 / 998
页数:11
相关论文
共 44 条
[1]
Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity [J].
Ackerman, Margaret E. ;
Alter, Galit .
CURRENT HIV RESEARCH, 2013, 11 (05) :365-377
[2]
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples [J].
Ackerman, Margaret E. ;
Moldt, Brian ;
Wyatt, Richard T. ;
Dugast, Anne-Sophie ;
McAndrew, Elizabeth ;
Tsoukas, Stephen ;
Jost, Stephanie ;
Berger, Christoph T. ;
Sciaranghella, Gaia ;
Liu, Qingquan ;
Irvine, Darrell J. ;
Burton, Dennis R. ;
Alter, Galit .
JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 366 (1-2) :8-19
[3]
[Anonymous], N ENGL J MED
[4]
Arnold K. B., 2015, MUCOSAL IMMUNOL
[5]
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys [J].
Barouch, Dan H. ;
Alter, Galit ;
Broge, Thomas ;
Linde, Caitlyn ;
Ackerman, Margaret E. ;
Brown, Eric P. ;
Borducchi, Erica N. ;
Smith, Kaitlin M. ;
Nkolola, Joseph P. ;
Liu, Jinyan ;
Shields, Jennifer ;
Parenteau, Lily ;
Whitney, James B. ;
Abbink, Peter ;
Ng'ang'a, David M. ;
Seaman, Michael S. ;
Lavine, Christy L. ;
Perry, James R. ;
Li, Wenjun ;
Colantonio, Arnaud D. ;
Lewis, Mark G. ;
Chen, Bing ;
Wenschuh, Holger ;
Reimer, Ulf ;
Piatak, Michael ;
Lifson, Jeffrey D. ;
Handley, Scott A. ;
Virgin, Herbert W. ;
Koutsoukos, Marguerite ;
Lorin, Clarisse ;
Voss, Gerald ;
Weijtens, Mo ;
Pau, Maria G. ;
Schuitemaker, Hanneke .
SCIENCE, 2015, 349 (6245) :320-324
[6]
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys [J].
Barouch, Dan H. ;
Stephenson, Kathryn E. ;
Borducchi, Erica N. ;
Smith, Kaitlin ;
Stanley, Kelly ;
McNally, Anna G. ;
Liu, Jinyan ;
Abbink, Peter ;
Maxfield, Lori F. ;
Seaman, Michael S. ;
Dugast, Anne-Sophie ;
Alter, Galit ;
Ferguson, Melissa ;
Li, Wenjun ;
Earl, Patricia L. ;
Moss, Bernard ;
Giorgi, Elena E. ;
Szinger, James J. ;
Eller, Leigh Anne ;
Billings, Erik A. ;
Rao, Mangala ;
Tovanabutra, Sodsai ;
Sanders-Buell, Eric ;
Weijtens, Mo ;
Pau, Maria G. ;
Schuitemaker, Hanneke ;
Robb, Merlin L. ;
Kim, Jerome H. ;
Korber, Bette T. ;
Michael, Nelson L. .
CELL, 2013, 155 (03) :531-539
[7]
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001) [J].
Barouch, Dan H. ;
Liu, Jinyan ;
Peter, Lauren ;
Abbink, Peter ;
Iampietro, M. Justin ;
Cheung, Ann ;
Alter, Galit ;
Chung, Amy ;
Dugast, Anne-Sophie ;
Frahm, Nicole ;
McElrath, M. Juliana ;
Wenschuh, Holger ;
Reimer, Ulf ;
Seaman, Michael S. ;
Pau, Maria G. ;
Weijtens, Mo ;
Goudsmit, Jaap ;
Walsh, Stephen R. ;
Dolin, Raphael ;
Baden, Lindsey R. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02) :248-256
[8]
Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity [J].
Black, KP ;
Cummins, JE ;
Jackson, S .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (02) :182-190
[9]
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity [J].
Bournazos, Stylianos ;
Klein, Florian ;
Pietzsch, John ;
Seaman, Michael S. ;
Nussenzweig, Michel C. ;
Ravetch, Jeffrey V. .
CELL, 2014, 158 (06) :1243-1253
[10]
Gastrointestinal Tract and the Mucosal Macrophage Reservoir in HIV Infection [J].
Brown, Dallas ;
Mattapallil, Joseph J. .
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (11) :1469-1473